<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940705-2-00206</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=81 g=1 f=1 --> Appendix I&hyph;II&hyph;B. Data To Be Submitted for Certification  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Appendix I&hyph;II&hyph;B&hyph;1. Host-Vector 1 Systems Other than Escherichia coli K&hyph;12.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The following types of data shall be submitted, modified as appropriate for the particular system under consideration: (i) a description of the organism and vector; the strain's natural habitat and growth requirements; its physiological properties, particularly those related to its reproduction, survival, and the mechanisms by which it exchanges genetic information; the range of organisms with which this organism normally exchanges genetic information and the type of information is exchanged; and any relevant information about its pathogenicity or toxicity; (ii) a description of the history of the particular strains and vectors to be used, including data on any mutations which render this organism less able to survive or transmit genetic information; and (iii) a general description of the range of experiments contemplated with emphasis on the need for developing such an Host-Vector 1 system.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Appendix I&hyph;II&hyph;B&hyph;2. Host-Vector 2 Systems.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Investigators planning to request Host-Vector 2 systems certification may obtain instructions from NIH/ORDA concerning data to be submitted (see Appendices I&hyph;III&hyph;N and O). In general, the following types of data are required: (i) description of construction steps with indication of source, properties, and manner of introduction of genetic traits; (ii) quantitative data on the stability of genetic traits that contribute to the containment of the system; (iii) data on the survival of the host-vector system under non-permissive laboratory conditions designed to represent the relevant natural environment; (iv) data on transmissibility of the vector and/or a cloned DNA fragment under both permissive and non-permissive conditions; (v) data on all other properties of the system which affect containment and utility, including information on yields of phage or plasmid molecules, ease of DNA isolation, and ease of transfection or transformation; and (vi) in some cases, the investigator may be asked to submit data on survival and vector transmissibility from experiments in which the host-vector is fed to laboratory animals or one or more human subjects. Such in vivo data may be required to confirm the validity of predicting in vivo survival on the basis of in vitro experiments. Data shall be submitted 12 weeks prior to the RAC meeting at which such data will be considered by the Office of Recombinant DNA Activities, National Institutes of Health, Building 31, room 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838. Investigators are encouraged to publish their data on the construction, properties, and testing of proposed Host Vector 2 systems prior to consideration of the system by the RAC and its subcommittee. Specific instructions concerning the submission of data for proposed  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Escherichia coli <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  K&hyph;12 Host-Vector 2 system (EK2) involving either plasmids or bacteriophage in  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Escherichia coli <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  K&hyph;12, are available from the Office of Recombinant DNA Activities, National Institutes of Health, Building 31, room 4B11, Bethesda, Maryland 20892, (301) 496&hyph;9838.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Appendix I&hyph;III. Footnotes and References of Appendix I  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Appendix I&hyph;III&hyph;A. Hersfield, V., H.W. Boyer, C. Yanofsky, M.A. Lovett, and D.R. Helinski, Plasmid Co1E1 as a Molecular Vehicle for Cloning and Amplification of DNA. Proc. Nat. Acad. Sci., 1974, 71, pp. 3455&hyph;3459.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;B. Wensink, P.C., D.J. Finnegan, J.E. Donelson, and D.S. Hogness, A System for Mapping DNA Sequences in the Chromosomes of Drosophila Melanogaster. Cell, 1974, 3, pp. 315&hyph;335.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;C. Tanaka, T., and B. Weisblum, Construction of a Colicin El-R Factor Composite Plasmid in Vitro: Means for Amplification of Deoxyribonucleic Acid. J. Bacteriol., 1975, 121, pp. 354&hyph;362.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;D. Armstrong, K.A., V. Hershfield, and D.R. Helinski, Gene Cloning and Containment Properties of Plasmid Col E1 and Its Derivatives, Science, 1977, 196, pp. 172&hyph;174.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;E. Bolivar, F., R.L. Rodriguez, M.C. Betlack, and H.W. Boyer, Construction and Characterization of New Cloning Vehicles: I. Ampicillin-Resistant Derivative of PMB9, Gene, 1977, 2, pp. 75&hyph;93.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;F. Cohen, S.N., A.C.W. Chang, H. Boyer, and R. Helling. Construction of Biologically Functional Bacterial Plasmids in Vitro. Proc. Natl. Acad, Sci., 1973, 70, pp. 3240&hyph;3244.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;G. Bolivar, F., R.L. Rodriguez, R.J. Greene, M.C. Batlack, H.L. Reyneker, H.W. Boyer, J.H. Cross, and S. Falkow, 1977, Construction and Characterization of New Cloning Vehicles II. A Multi-Purpose Cloning System, Gene, 1977, 2, pp. 95&hyph;113.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;H. Thomas, M., J.R. Cameron, and R.W. Davis (1974). Viable Molecular Hybrids of Bacteriophage Lambda and Eukaryotic DNA. Proc. Nat. Acad. Sci., 1974, 71, pp. 4579&hyph;4583.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;I. Murray, N.E., and K. Murray, Manipulation of Restriction Targets in Phage Lambda to Form Receptor Chromosomes for DNA Fragments. Nature, 1974, 51, pp. 476&hyph;481.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Appendix I&hyph;III&hyph;J. Ramback, A., and P. Tiollais (1974). Bacteriophage Having EcoRI Endonuclease Sites Only in the Non-Essential Region of the Genome. Proc. Nat. Acad. Sci., 1974, 71, pp. 3927&hyph;3820.  <!-- PJG 0012 frnewline -->   <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            